Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer

NCT07025850 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

DRUG: Digoxin
DRUG: Fuquinitinib
DRUG: Tislelizumab

Sponsor

Fudan University

Collaborators

[object Object]